Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver and its
mortality is third among all solid tumors, behind carcinomas of the lung and the colon …

Purpose To further improve the effectiveness and prognosis of primary hepatocellular
carcinoma (HCC) with portal vein tumor thrombus (PVTT), the current status of treatment for …

Objectives To evaluate the feasibility and efficacy of stereotactic body radiation therapy
(SBRT) in the treatment of hepatocellular carcinoma (HCC) unsuitable for standard loco …

Purpose To perform a systematic review and meta-analysis to compare the clinical
outcomes and toxicity of hepatocellular carcinoma (HCC) patients treated with charged …

Stereotactic body radiation therapy (SBRT) has an evolving role in the management of
hepatocellular carcinoma (HCC), largely due to recent advances in imaging technology …

Background The survival following transarterial chemoembolization (TACE) alone is still low
in unresectable hepatocellular carcinoma (HCC) with almost patients develo** disease …

With increasing clinical use, radiotherapy (RT) has been considered reliable and effective
method for hepatocellular carcinoma (HCC) treatment, depending on extent of disease and …

Background To evaluate the efficacy and toxicity of stereotactic body radiotherapy (SBRT) in
the treatment of advanced hepatocellular carcinoma (HCC). Material and Methods Patients …

The current management therapies for hepatocellular carcinoma (HCC) patients are
discussed in this review. Despite the development of new therapies, HCC remains a “difficult …

Patients with liver cirrhosis and hepatocellular carcinoma (HCC) are often ineligible for
resection or local ablation therapy due to poor liver function and/or difficult location. The aim …